
|Videos|November 10, 2022
Institutional Perspectives in Neurology, Chaired by Robert T. Naismith, MD
Author(s)NeurologyLive® Staff
Chaired by Robert T. Naismith, MD, of Washington University in St. Louis, the presentations also feature Salim Chahin, MD, MSCE; Anne H. Cross, MD; Gregory F. Wu, MD, PhD; and Matthew R. Brier, MD, PhD. [WATCH TIME: 1 hour, 55 minutes]
Advertisement
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
TOPICS INCLUDE:
- 02:45 – ECTRIMS Case Presentation: Evidence-Based MS Care — Robert T. Naismith, MD
- 17:25 – Pro: Epstein-Barr Virus Causes Multiple Sclerosis — Anne H. Cross, MD
- 38:30 – Con: Epstein-Barr Virus Causes Multiple Sclerosis — Gregory F. Wu, MD, PhD
- 56:20 – Question & Answer
- 1:08:10 – Choosing a DMT — Salim Chahin, MD, MSCE
- 1:23:55 – Clinical Neuroimaging in MS: More Than Counting Lesions — Matthew R. Brier, MD, PhD
- 1:39:55 – Question & Answer
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New 3-Year EMBARK Data Highlights Continued Therapeutic Effect of Gene Therapy Elevidys in Duchenne
2
FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials
3
Phase 2 Study of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy: The REVISE Trial
4
Priority Review Granted for Weekly Subcutaneous Lecanemab Dosing in Early Alzheimer Disease
5










